GSA Capital Partners’s VivoSim Labs VIVS Stock Holding History

GSA Capital Partners’s Portfolio VIVS Stock Details VIVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-114	Closed	-$72K	–	1921
2017 Q2	$72K	Buy	+114	New	+$76.6K	﹤0.01%	1611

Other funds holding VIVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

GSA Capital Partners's VIVS Position: Q3 2017 in Review

GSA Capital Partners sold out of VivoSim Labs (VIVS) in Q3 2017, closing a stake of 114 shares — an estimated $72K sold.

GSA Capital Partners first reported a position in VIVS in Q2 2017 and held it in 1 quarter. The position peaked at $72K in Q2 2017. 119 funds tracked by Wall St. Rank hold VIVS as of Q3 2017.

GSA Capital Partners reported no remaining VivoSim Labs position as of Q3 2017 after selling out during the quarter.
GSA Capital Partners sold 114 VivoSim Labs shares in Q3 2017, an estimated $72K.
GSA Capital Partners first reported a position in VivoSim Labs in Q2 2017 and held it in 1 quarter.
GSA Capital Partners's VivoSim Labs position peaked at $72K in Q2 2017.
119 funds tracked by Wall St. Rank held VivoSim Labs as of Q3 2017.

Based on GSA Capital Partners's 13F filing for Q3 2017, filed 20 Nov 2017.